Cisplatin hipec
WebMar 4, 2024 · Overall, cisplatin has been used as a HIPEC agent, alone or in combination, in 76% of mesothelioma patients treated with this technic. The summary of selected studies in Table 2 showed discrepancies in complete cytoreduction rates, a trend of a better 5-year OS after cisplatin-doxorubicin HIPEC with less severe complications. Mono-drug Regimen WebHIPEC with cisplatin plus oral S-1 is a safe and effective adjuvant therapy for patients with advanced gastric cancer following D2 radical gastrectomy. Trial registration: This study was registered at ClinicalTrials.gov with the identifier (NCT number): NCT02396498 Keywords: Gastric cancer hyperthermic intraperitoneal chemotherapy (HIPEC) S-1
Cisplatin hipec
Did you know?
WebHIPEC with cisplatin (CDDP) has proven interesting in long-term survival for these conditions [Citation 1–5]. The main side effect of CDDP is its acute and chronic nephrotoxicity, whether used systemically or intraperitoneally. First, CDDP induces early proximal renal tubular damage, leading to an acute or subacute tubular necrosis ... WebMay 2, 2024 · Objectives: Cisplatin is commonly used during intraperitoneal chemotherapy however has well-established nephrotoxic side-effects. Sodium thiosulfate is often added to cisplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) protocols to mitigate this, however evidence regarding risk of hypernatraemia is scarce as of yet.
WebApr 12, 2024 · Objective . To assess the clinical efficacy and safety of cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer. Methods . From April 2024 to November 2024, 66 patients with ovarian cancer were admitted to our hospital and randomly allocated to undergo intravenous chemotherapy following CRS … WebDec 11, 2024 · The objective of this study is to prove that treatment with primary cytoreductive surgery in combination with HIPEC (treatment arm) improves outcome compared to primary cytoreductive surgery without HIPEC (standard arm) with acceptable morbidity, in patients with FIGO stage III epithelial ovarian cancer who are eligible for …
WebApr 23, 2024 · Hyperthermic Intraperitoneal Chemotherapy with Cisplatin and Paclitaxel Improves Progression-Free Survival Compared with Cisplatin Alone. In HIPEC, combination cisplatin/paclitaxel may more than double progression free survival compared with cisplatin alone, according to a new study. WebJan 27, 2024 · Cisplatin is one of the most widely used chemotherapeutic agents in oncology, although its nephrotoxicity limits application and dosage. We present the results of a clinical study on prophylaxis of cisplatin-induced nephrotoxicity in patients with peritoneal carcinomatosis undergoing cytoreduction a …
WebMar 26, 2024 · Cisplatin/paclitaxel boosts outcomes without increasing complications in registry study. By Charles Bankhead Two drugs outperformed one for hyperthermic intraperitoneal chemotherapy (HIPEC) after interval surgical debulking of advanced ovarian cancer, data from a prospective registry showed.
WebJun 2, 2024 · Conclusions: HIPEC with cisplatin results in significant renal toxicities. The mechanisms of cisplatin-induced nephrotoxicity in HIPEC are immune-related and reflect reduced metabolism. Sodium thiosulfate abrogated renal toxicities and did not decrease PFS. Clinical trial information: NCT01970722. © 2024 by American Society of Clinical … dickinson county extension officeWebIntraperitoneal hyperthermic chemoperfusion ( HIPEC or IPHC) is a type of hyperthermia therapy used in combination with surgery in the treatment of advanced abdominal cancers. [1] In this procedure, warmed anti-cancer medications are infused and circulated in the peritoneal cavity (abdomen) for a short period of time. citrate in blood bagsWebJul 24, 2024 · Intraperitoneal chemoperfusion (IPEC) of cisplatin is a popular treatment for advanced ovarian cancer, typically under hyperthermia (HIPEC). The use of cisplatin under (H)IPEC is off-label, and the role of hyperthermia is unknown. dickinson county extension office abilene ksWebMar 26, 2024 · HIPEC treatment selection was nonrandomized and was at the discretion of the primary surgeon. HIPEC was performed with in-flow and out-flow tubing into the abdomen and connected to a profusion pump, with the laparotomy incision closed to ensure airtight seal. Cisplatin was administered at 100 mg/m 2 with or without paclitaxel at 135 … citrated whole bloodWebFollowing CRS, we use a closed abdomen HIPEC technique and perfuse with cisplatin according to the National Cancer Institute (NCI)–described protocol with sodium thiosulfate given intravenously. 58 Due to a paucity of trials and comparison studies, there is no standardized HIPEC technique, and a variety of chemoperfusion regimens are ... dickinson county dmv iowaWebMultivariate analysis showed that HIPEC regimen was the main risk factor of hepatotoxicity induced by HIPEC, with cisplatin + docetaxel being an independent risk factor of the HIPEC-induced hepatotoxicity. Open HIPEC techniques and HIPEC duration more than 60 minutes tend to increase the incidence of hepatotoxicity. Conclusion: Surgery + HIPEC ... citrate inhibits phosphofructokinaseWebBackground: Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with cytoreductive surgery (CRS) is the treatment of choice for selected patients with peritoneal malignancies. HIPEC is accompanied by moderate-to-high patient morbidity, including acute kidney injury. The significance of nephrotoxic agents such as cisplatin versus … citrate in body